Product Name

  • Name

    MORPHOLIN-4-YL-ACETIC ACID

  • EINECS
  • CAS No. 3235-69-6
  • Article Data32
  • CAS DataBase
  • Density 1.202 g/cm3
  • Solubility
  • Melting Point 162-164 °C
  • Formula C6H11NO3
  • Boiling Point 271.898 °C at 760 mmHg
  • Molecular Weight 145.158
  • Flash Point 118.24 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes 36
  • Molecular Structure Molecular Structure of 3235-69-6 (MORPHOLIN-4-YL-ACETIC ACID)
  • Hazard Symbols IrritantXi
  • Synonyms 2-(4-Morpholinyl)aceticacid;2-(Morpholino)acetic acid;Morpholinoacetic acid;N-(Carboxymethyl)morpholine;
  • PSA 49.77000
  • LogP -0.65890

Synthetic route

(4-morpholinyl)acetic acid 1,1-dimethylethyl ester
88217-68-9

(4-morpholinyl)acetic acid 1,1-dimethylethyl ester

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran at 0℃; for 0.5h; Hydrolysis;100%
In water; isopropyl alcohol at 160℃; for 0.4h; Solvent; Temperature; Flow reactor;95%
With trifluoroacetic acid In dichloromethane at 20℃; for 5h;
benzyl morpholino-acetate
53342-23-7

benzyl morpholino-acetate

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In methanol for 40h;98%
With potassium tert-butylate In tetrahydrofuran at 0℃; for 5h; Hydrolysis;97%
N-morpholylacetic acid ethyl ester
3235-82-3

N-morpholylacetic acid ethyl ester

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
With hydrogenchloride In water at 95℃; for 16h; Temperature; Time;96.3%
With water for 30h; Hydrolysis; Heating;87%
With sodium hydroxide In water Heating;65%
methyl 2-morpholin-4-ylacetate
35855-10-8

methyl 2-morpholin-4-ylacetate

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
Stage #1: methyl 2-morpholin-4-ylacetate With methanol; sodium hydroxide; water In tetrahydrofuran at 50℃; for 1h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water pH=3;
90%
With water; lithium hydroxide In methanol at 20℃; for 3h; Inert atmosphere;
morpholine
110-91-8

morpholine

bromoacetic acid
79-08-3

bromoacetic acid

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Inert atmosphere;85.3%
morpholine
110-91-8

morpholine

bromoacetic acid tert-butyl ester
5292-43-3

bromoacetic acid tert-butyl ester

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
In tetrahydrofuran; hydrogenchloride; ethyl acetate85%
In tetrahydrofuran; hydrogenchloride; ethyl acetate85%
morpholine
110-91-8

morpholine

4-(morpholinomethyl)morpholine
5625-90-1

4-(morpholinomethyl)morpholine

potassium cyanide
151-50-8

potassium cyanide

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
With water
morpholine
110-91-8

morpholine

sodium monochloroacetic acid
3926-62-3

sodium monochloroacetic acid

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
With water
5-(2-morpholinoacetamido)-3,3-di-p-tolyl-2-indolinone hydrochloride

5-(2-morpholinoacetamido)-3,3-di-p-tolyl-2-indolinone hydrochloride

A

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

B

5-Amino-3,3-di-p-tolyl-1,3-dihydro-indol-2-one

5-Amino-3,3-di-p-tolyl-1,3-dihydro-indol-2-one

Conditions
ConditionsYield
With hydrogenchloride; water In acetic acid at 69.9 - 95.9℃; Rate constant; Kinetics; Thermodynamic data; ΔS(activ.), ΔH(activ.), ΔG(activ.);
morpholine
110-91-8

morpholine

chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; benzene
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

(S)-benzyl 2-((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanamido)-4-methylpentanoate hydrogen chloride salt

(S)-benzyl 2-((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanamido)-4-methylpentanoate hydrogen chloride salt

(S)-benzyl 4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanoate
1385032-88-1

(S)-benzyl 4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanoate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 20℃;98%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

(S)-2-amino-N4-(tert-butoxy)-N1-((S)-1-((naphthalen-1-ylmethyl)amino)-1-oxopropan-2-yl)succinamide

(S)-2-amino-N4-(tert-butoxy)-N1-((S)-1-((naphthalen-1-ylmethyl)amino)-1-oxopropan-2-yl)succinamide

(S)-N4-(tert-butoxy)-2-(2-morpholinoacetamido)-N1-((S)-1-((naphthalen-1-ylmethyl)amino)-1-oxopropan-2-yl)succinamide

(S)-N4-(tert-butoxy)-2-(2-morpholinoacetamido)-N1-((S)-1-((naphthalen-1-ylmethyl)amino)-1-oxopropan-2-yl)succinamide

Conditions
ConditionsYield
With 1-hydroxy-7-aza-benzotriazole; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide98%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

2,5-dioxopyrrolidin-1-yl 2-morpholinoacetate

2,5-dioxopyrrolidin-1-yl 2-morpholinoacetate

Conditions
ConditionsYield
With thionyl chloride In tetrahydrofuran; N,N-dimethyl-formamide at 20℃;96%
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 1h;78%
With thionyl chloride; N,N-dimethyl-formamide In tetrahydrofuran at 0 - 20℃;67%
With thionyl chloride; N,N-dimethyl-formamide In tetrahydrofuran at 20℃;
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

(8S,9S,10R,13S,14S,17S)-17-((E)-1-(hydroxyimino)ethyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)one

(8S,9S,10R,13S,14S,17S)-17-((E)-1-(hydroxyimino)ethyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)one

(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-((E)-1-(2-morpholinoacetoxyimino)ethyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
1364709-87-4

(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-((E)-1-(2-morpholinoacetoxyimino)ethyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 18h; Inert atmosphere;94%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

(8S,9S,10R,13S,14S,17S)-17-((E)-1-(hydroxyimino)ethyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
1364709-15-8

(8S,9S,10R,13S,14S,17S)-17-((E)-1-(hydroxyimino)ethyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-((E)-1-(2-morpholinoacetoxyimino)ethyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
1364709-87-4

(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-((E)-1-(2-morpholinoacetoxyimino)ethyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 18h; Inert atmosphere;94%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 18h; Inert atmosphere;94%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

methyl 3-(4-chlorophenylamino)propanoate
21911-88-6

methyl 3-(4-chlorophenylamino)propanoate

C16H21ClN2O4

C16H21ClN2O4

Conditions
ConditionsYield
Stage #1: morpholin-4-ylacetic acid With thionyl chloride In dichloromethane at 10 - 20℃; for 2h;
Stage #2: methyl 3-(4-chlorophenylamino)propanoate With triethylamine In dichloromethane at 20℃; for 2.5h; Temperature;
92%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

C39H58O5

C39H58O5

C45H67NO7

C45H67NO7

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;92%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

(E)-4-(2-phenyl-1-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)but-1-en-1-yl)aniline

(E)-4-(2-phenyl-1-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)but-1-en-1-yl)aniline

(E)-2-morpholino-N-(4-(2-phenyl-1-(4-(2-(pyrrolidin-1-yl)-ethoxy)phenyl)but-1-en-1-yl)phenyl)acetamide

(E)-2-morpholino-N-(4-(2-phenyl-1-(4-(2-(pyrrolidin-1-yl)-ethoxy)phenyl)but-1-en-1-yl)phenyl)acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 4h; Inert atmosphere;91%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

1-adamantan-1-yl-2-(5,6,7,8-tetrahydro-pyrido[3,4-d]pyrimidin-4-ylamino)-ethanol

1-adamantan-1-yl-2-(5,6,7,8-tetrahydro-pyrido[3,4-d]pyrimidin-4-ylamino)-ethanol

1-[4-(2-adamantan-1-yl-2-hydroxy-ethylamino)-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl]-2-morpholin-4-yl-ethanone

1-[4-(2-adamantan-1-yl-2-hydroxy-ethylamino)-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl]-2-morpholin-4-yl-ethanone

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;90%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

C20H29N5O6

C20H29N5O6

C21H30N6O6

C21H30N6O6

Conditions
ConditionsYield
Stage #1: C20H29N5O6 With trifluoroacetic acid
Stage #2: morpholin-4-ylacetic acid With HCTU; N-ethyl-N,N-diisopropylamine In dichloromethane
90%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

3-Iodoaniline
626-01-7

3-Iodoaniline

C12H15IN2O2

C12H15IN2O2

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide Inert atmosphere;89.9%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

(S)-N-((S)-2-amino-1-cyclohexylethyl)-3-(6-isopropylbenzo[d]thiazol-2-yl)-2-propionamidopropanamide

(S)-N-((S)-2-amino-1-cyclohexylethyl)-3-(6-isopropylbenzo[d]thiazol-2-yl)-2-propionamidopropanamide

(S)-N-((S)-1-cyclohexyl-2-(2-morpholinoacetamido)ethyl)-3-(6-isopropylbenzo[d]thiazol-2-yl)-2-propionamidopropanamide

(S)-N-((S)-1-cyclohexyl-2-(2-morpholinoacetamido)ethyl)-3-(6-isopropylbenzo[d]thiazol-2-yl)-2-propionamidopropanamide

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1h;87%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

2-Morpholinoessigsaeure-N-oxid
87439-12-1

2-Morpholinoessigsaeure-N-oxid

Conditions
ConditionsYield
With dihydrogen peroxide In acetic acid at 60℃; for 12h;86%
Brivanib
649735-46-6

Brivanib

morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

C25H28FN5O5
1016195-07-5

C25H28FN5O5

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; dmap In N,N-dimethyl-formamide85%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

C31H34F26O5
1021458-90-1

C31H34F26O5

C37H43F26NO7
1021458-80-9

C37H43F26NO7

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 72h;84%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

C41H52F12O7
1021458-94-5

C41H52F12O7

C47H61F12NO9
1021458-71-8

C47H61F12NO9

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h;82%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

(E)-4-(1-(4-(2-morpholinoethoxy)phenyl)-2-phenylbut-1-en-1-yl)aniline

(E)-4-(1-(4-(2-morpholinoethoxy)phenyl)-2-phenylbut-1-en-1-yl)aniline

(E)-2-morpholino-N-(4-(1-(4-(2-morpholinoethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenyl)acetamide

(E)-2-morpholino-N-(4-(1-(4-(2-morpholinoethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenyl)acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 4h; Inert atmosphere;82%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

(S)-3-(3-(7-(3-aminopropoxy)-5-carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-1H-benzo[d]imidazol-1-yl)propyl)-2-(1-ethyl-4-fluoro-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxamide hydrochloride

(S)-3-(3-(7-(3-aminopropoxy)-5-carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-1H-benzo[d]imidazol-1-yl)propyl)-2-(1-ethyl-4-fluoro-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxamide hydrochloride

(S)-3-(3-(5-carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-(2-morpholinoacetamido)propoxy)-1H-benzo[d]imidazol-1-yl)propyl)-2-(1-ethyl-4-fluoro-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxamide

(S)-3-(3-(5-carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-(2-morpholinoacetamido)propoxy)-1H-benzo[d]imidazol-1-yl)propyl)-2-(1-ethyl-4-fluoro-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxamide

Conditions
ConditionsYield
With benzotriazol-1-ol; HATU In N,N-dimethyl-formamide at 20 - 27℃;81%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

N-(3S-amino-2R-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitro-benzenesulfonamide hydrochloride
251105-80-3

N-(3S-amino-2R-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitro-benzenesulfonamide hydrochloride

N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-nitrophenyl)sulfonamido)-1-phenylbutan-2-yl)-2-morpholinoacetamide

N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-nitrophenyl)sulfonamido)-1-phenylbutan-2-yl)-2-morpholinoacetamide

Conditions
ConditionsYield
Stage #1: morpholin-4-ylacetic acid; N-(3S-amino-2R-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitro-benzenesulfonamide hydrochloride With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 25℃; Inert atmosphere; Sealed tube;
Stage #2: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 25℃; Inert atmosphere; Sealed tube;
80%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

sofosbuvir
1190307-88-0

sofosbuvir

isopropyl ((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyl-3-(2-morpholinoacetoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate

isopropyl ((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyl-3-(2-morpholinoacetoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate

Conditions
ConditionsYield
Stage #1: morpholin-4-ylacetic acid; sofosbuvir With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 0.0833333h;
Stage #2: With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate In dichloromethane for 20h;
76%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

C37H56O4

C37H56O4

C43H65NO6

C43H65NO6

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;75.9%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

C11H15N3O3

C11H15N3O3

C17H24N4O5

C17H24N4O5

Conditions
ConditionsYield
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 24h; Enzymatic reaction;75%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-methoxybenzenesulfonamide
159005-71-7

N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-methoxybenzenesulfonamide

N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)-2-morpholinoacetamide

N-((2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl)-2-morpholinoacetamide

Conditions
ConditionsYield
Stage #1: morpholin-4-ylacetic acid; N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-methoxybenzenesulfonamide With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 25℃; Inert atmosphere; Sealed tube;
Stage #2: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 25℃; Inert atmosphere; Sealed tube;
75%
morpholin-4-ylacetic acid
3235-69-6

morpholin-4-ylacetic acid

C13H18N2O4*C2HF3O2

C13H18N2O4*C2HF3O2

(S)-methyl 3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanoate
1620107-79-0

(S)-methyl 3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In tetrahydrofuran for 1h;75%

Morpholin-4-ylacetic acid Chemical Properties


Molecular Formula: C6H11NO3
Molecular Weight: 145.16 g/mol
Canonical SMILES: O=C(O)CN1CCOCC1
InChI: InChI=1/C6H11NO3/c8-6(9)5-7-1-3-10-4-2-7/h1-5H2,(H,8,9)
Mol File: 3235-69-6.mol
Product Categories: Amino Acids and Derivatives
Nominal Mass: 145
Average Mass: 145.1564
Monoisotopic Mass: 145.073893
H bond acceptors: 4
H bond donors: 1
#Freely Rotating Bonds: 2
Polar Surface Area: 38.77
Index of Refraction: 1.483
Molar Refractivity: 34.5 cm3
Molar Volume: 120.7 cm3
Polarizability: 13.68×10-24cm3
Surface Tension: 43.1 dyne/cm
Density: 1.202 g/cm3
Flash Point: 118.2 °C
Enthalpy of Vaporization: 56.15 kJ/mol
Boiling Point: 271.9 °C at 760 mmHg
Vapour Pressure of 4-Morpholineacetic acid (CAS NO.3235-69-6): 0.00175 mmHg at 25 °C

Morpholin-4-ylacetic acid Safety Profile

Hazard Codes: IrritantXi
HazardClass of 4-Morpholineacetic acid (CAS NO.3235-69-6): Irritant

Morpholin-4-ylacetic acid Specification

 4-Morpholineacetic acid (CAS NO.3235-69-6), its synonyms are 2-(4-Morpholinyl)acetic acid ;
Morpholineacetic acid ; Morpholin-4-yl-acetic acid ; 4-Morpholine acetic acid .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View